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Abstract
Background: LmrA is a multidrug ATP-binding cassette (ABC) transporter from Lactococcus lactis with no known
physiological substrate, which can transport a wide range of chemotherapeutic agents and toxins from the cell. The protein
can functionally replace the human homologue ABCB1 (also termed multidrug resistance P-glycoprotein MDR1) in lung
fibroblast cells. Even though LmrA mediates ATP-dependent transport, it can use the proton-motive force to transport
substrates, such as ethidium bromide, across the membrane by a reversible, H
+-dependent, secondary-active transport
reaction. The mechanism and physiological context of this reaction are not known.
Methodology/Principal Findings: We examined ion transport by LmrA in electrophysiological experiments and in transport
studies using radioactive ions and fluorescent ion-selective probes. Here we show that LmrA itself can transport NaCl by a
similar secondary-active mechanism as observed for ethidium bromide, by mediating apparent H
+-Na
+-Cl
2 symport.
Remarkably, LmrA activity significantly enhances survival of high-salt adapted lactococcal cells during ionic downshift.
Conclusions/Significance: The observations on H
+-Na
+-Cl
2 co-transport substantiate earlier suggestions of H
+-coupled
transport by LmrA, and indicate a novel link between the activity of LmrA and salt stress. Our findings demonstrate the
relevance of investigations into the bioenergetics of substrate translocation by ABC transporters for our understanding of
fundamental mechanisms in this superfamily. This study represents the first use of electrophysiological techniques to
analyze substrate transport by a purified multidrug transporter.
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Introduction
In order to evade the toxic effects of noxious compounds,
prokaryotic and eukaryotic cells have developed several resistance
mechanisms. One of these mechanisms involves the active
extrusion of structurally-unrelated compounds from the cell by
multidrug transporters [1]. The expression of these systems is a
major cause of reduced efficacy of agricultural fungicides and
herbicides [2,3], and failure of chemotherapeutic treatment of
tumours [4–6] and infections by pathogenic microorganisms [7].
Since the discovery of the human multidrug transporter ABCB1
(also termed multidrug resistance P-glycoprotein MDR1) [8,9],
homologues of ABCB1 have been identified in a variety of
microorganisms. Among these, one of the most extensively studied
proteins is LmrA from the non-pathogenic bacterium Lactococcus
lactis [10].
LmrA is a half-transporter that contains an N-terminal
membrane domain (MD) followed by a nucleotide-binding
domain (NBD). By analogy to ABCB1 in which two half-
transporters are fused into a single polypeptide, LmrA homo-
dimerises to form the transport-active complex [11]. LmrA can
functionally substitute for ABCB1 in human lung fibroblasts, and
exhibits a substrate specificity similar to that of the human protein
[12]. Its specificity is also similar to that of bacterial homologues
such as HorA in Lactobacillus brevis, which is associated with
resistance to iso-a-acids (in hopped beer) at increased copy
number of the horA-containing plasmid pRH45 [13,14], and the
recently crystallized, genomically-encoded MsbA from Escherichia
coli, Salmonella typhimurium, and Vibrio cholera [15–19] and Sav1866
from Staphylococcus aureus [20,21]. Studies on the pharmacological
properties of multidrug ABC transporters (reviewed in
[1,19,22,23]) revealed that the ability of these systems to transport
multiple drugs is based on direct drug-protein interactions. A
recent crystal structure of mouse ABCB1a demonstrates substrate
binding at the top of an internal cavity at the dimer interface
between the two half-transporters near the leaflet-leaflet interface
of the membrane [24], consistent with biochemical observations
on MsbA [19].
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6137Gram-positive lactic acid bacteria play an important role in the
food industry due to their fermentative capacities [25]. L. lactis is
the main component of the starter cultures used for cheese
making. Its main activity during milk fermentation is the
conversion of lactose to lactic acid, which results in the lowering
of the pH in the product to prevent the growth of spoilage and
pathogenic microorganisms [26]. During this process as well as in
its natural habitats, L. lactis is subjected to stressful conditions
which, in addition to acidity, include exposure to antibacterial
peptides (e.g. bacteriocins), toxic metabolic products (e.g. bile salts
and fatty acids), secondary metabolites (e.g. antibiotics), and high
osmolarity/dehydration; NaCl is an important constituent of
cheese which can reach concentrations of up to 0.5 M.
In this paper, we report that LmrA can mediate a H
+-Na
+-Cl
2
symport reaction and can enhance survival of salt-adapted cells
during downshifts in the extracellular ion concentration. Obser-
vations on the redundancy and overlapping drug specificities of
multidrug ABC transporters [27] and the examples of regulation
of their expression independent of multiple drugs [28] have
indicated that some of these ABC transporters might have
alternative or additional physiological roles. Our findings on
LmrA now provide an interesting example of this notion.
Results
Purified LmrA-MD and LmrA do not contain additional
binding partners
In previous work in L. lactis, we engineered a truncated LmrA
protein, termed LmrA-MD, which lacks the NBD [29]. Studies on
the purified protein in proteoliposomes revealed that homodimeric
LmrA-MD functions as a secondary-active multidrug translocator
by catalyzing reversible ethidium-proton symport without a
requirement for ATP [30]. This observation was recently extended
to full-length LmrA in proteoliposomes [31]. As our observations
on ion-coupled transport are the first reported for a purified
multidrug ABC transporter, we used a recently described method
involving nano-electrospray mass spectrometry [32] to confirm the
subunit stoichiometry, lipid binding, and purity of our prepara-
tions of LmrA and LmrA-MD. Predominant well-resolved peaks
corresponded to molecular masses of 132233626 Da and
80140617 Da and were consistent with homodimers of LmrA
and LmrA-MD (Figure 1); calculated molecular masses of the
dimeric complexes were 132312 and 80218 Da, respectively.
Peaks corresponding to tetramers of LmrA and LmrA-MD were
also observed in both spectra and are likely due to a low level of
association of dimers within the micelles. Lipid binding was also
evident for both proteins with masses consistent with a cardiolipin
(1352 Da). Notably our protein preparations did not contain
additional (membrane) proteins that could act as binding partners
of LmrA or LmrA-MD.
Ionic currents in LmrA-MD-containing proteoliposomes
We studied the mechanism of ion transport by LmrA-MD in
more detail. Surprisingly, when proteoliposomes containing
purified and functionally reconstituted LmrA-MD were fused
with a phospholipid bilayer in the tip of a glass pipette,
macroscopic currents associated with thousands of LmrA-MD
molecules could be recorded in response to hyper- or depolarizing
pulses from a holding potential of 0 mV (Figure 2A). The current
changed linearly with voltage and showed no evidence for
rectification, indicating comparable rates of ion conductance in
uptake and efflux directions (Figure 2B). No significant currents
could be recorded for empty control liposomes (Figure 2C) or
proteoliposomes containing a mutant LmrA-MD protein in which
two basic residues (K32 and R34) in the cytosolic N-terminal
elbow helix are replaced by E (termed EE LmrA-MD) (Figure 2D).
Figure 1. Mass spectra of purified LmrA and LmrA-MD showing predominant homodimer formation for both proteins. Peaks
assigned to binding of one cardiolipin molecule are labelled (blue stars), and measured molecular masses are shown.
doi:10.1371/journal.pone.0006137.g001
H
+-Na
+-Cl
2 Symport by LmrA
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addition, the mutation did not alter ethidium and Hoechst 33342
binding by purified LmrA-MD or LmrA in detergent solution, or
the basal ATPase activity of the latter, suggesting that no gross
conformational changes were introduced (data not shown).
Currents were also absent upon the replacement of Cl
2 in the
internal and external bath solutions by SO4
22, and were strongly
reduced by the replacement of K
+ and Na
+ by N-methyl-D-
glucosamine
+ (NMG
+) (Figure 2E–G), demonstrating that the
currents are a result of LmrA-MD mediated Cl
2 and Na
+ and/or
K
+ transport.
Proton-coupled chloride transport
The transport of Cl
2 in LmrA-MD-containing proteoliposomes
was further studied in transport assays using radioactive
36Cl
2.
Upon the imposition of a transmembrane potential (Dy)o f
2120 mV (inside negative), proteoliposomes accumulated
36Cl
2
about 17.4-fold above the equilibration level obtained for empty
liposomes ([Cl
2]in=2.7960.07 mM for LmrA-MD versus
0.1660.04 mM for control) (Figure 3A). In contrast,
36Cl
2
transport by the EE LmrA-MD was strongly reduced and almost
identical to levels in empty liposomes. The accumulation of Cl
2 by
wildtype LmrA-MD at the negative side of the proteoliposomal
membrane points to the electrogenic co-transport of Cl
2 and
cations.
One type of cation that is co-transported with Cl
2 is H
+. The
imposition of a transmembrane chemical proton gradient (-ZDpH,
interior alkaline) of 249 mV in proteoliposomes by the outward
diffusion on acetic acid (pH 7.6in/pH 6.8out) [29] (Figure 3B) was
accompanied by a 4.2-fold accumulation of
36Cl
2 above the
equilibration level in empty liposomes ([Cl
2]in=1.6160.12 mM
for LmrA-MD versus 0.3860.08 mM for control). Uptake by EE
LmrA-MD was comparable to control. The addition of an
uncoupler that dissipated the imposed DpH initiated efflux of
previously accumulated
36Cl
2, providing evidence for concentra-
tive ion uptake by LmrA-MD (Figure 3B). The uphill movement of
Cl
2 against a concentration gradient at the expense of H
+ moving
downhill is consistent with the notion that LmrA-MD act as a
transporter. The uptake of
36Cl
2 was also observed when a DpH
(interior alkaline) was imposed by pH jump (pH 7.6in/pH 6.8out),
but not upon imposition of a reversed DpH (pH 6.8in/pH 7.6out)
by this method (data not shown). Previous findings on ethidium-
proton co-transport by LmrA-MD and LmrA indicated that the
E314A substitution in transmembrane helix 6 abrogates DpH-
dependence but not Dy-dependence of this reaction [29,30]. In
agreement with this, the E314A mutation strongly inhibited the
DpH-dependent transport of
36Cl
2, whereas the Dy-mediated
transport was unaffected (Figure 3A–B).
The observations for LmrA-MD were also relevant for full-
length LmrA, as DpH (pH 7.6in/pH 6.8out)-driven uptake of
36Cl
2 resulted in a 4.4-fold accumulation of the ion in
proteoliposomes containing LmrA compared to empty liposomes
([Cl
2]in=1.5460.20 mM for LmrA versus 0.3560.08 mM for
control) (Figure 3C). The DpH (interior alkaline)-dependent
uptake of Cl
2 could also be detected when a Cl
2-sensitive
fluorophore was trapped in the liposomal lumen (Figure 3D). The
accumulation of Cl
2 was observed as a fluorescence quenching
with an initial rate of (46.260.9)610
23 a.u./s in LmrA-containing
proteoliposomes versus (13.267.6)610
23 a.u./s in empty lipo-
somes. Upon the addition of the Cl
2/OH
2 ion exchanger
tributylin chloride (TBT-Cl) to the liposomes in the presence of the
DpH, a similar quenching of fluorescence was obtained as that
associated with LmrA activity (Figure 3D), supporting the notion
that LmrA mediates chloride-proton co-transport. Measurement
of the rate of DpH-dependent
36Cl
2 transport by LmrA as a
function of the Cl
2 concentration indicated a high apparent
affinity (Michaelis constant, Km) of 17.963.7 mMC l
2 and a
maximum transport rate (Vmax) of about 142 nmol/min/mg
protein (Figure 3E). This Vmax is comparable to the maximum
ATPase activity of purified LmrA (about 150 nmol/min/mg
Figure 2. Electrophysiological analyses of ion transport in proteoliposomes by ‘dip-tip’ method. A, Voltage step protocol from a
holding potential of 0 mV to various voltages (ranging from 2105 mV to +115 mV), back to 0 mV. B, C, D, Current traces for LmrA-MD (B) or empty
liposomes without protein (C) or EE LmrA-MD (D) in the presence of 10 mM NaCl. E, F, Current traces for LmrA-MD in the presence of SO4
22 instead
of Cl
2 (E), or NMG
+ instead of Na
+ and K
+ (F). G, I–V curves from the traces in (B–F) (#, LmrA-MD;N, replacement of Cl
2 by SO4
22; %, replacement of
K
+/Na
+ by NMG
+; ,, EE; n, empty liposomes; the latter two traces are hidden behindN). (n=15)
doi:10.1371/journal.pone.0006137.g002
H
+-Na
+-Cl
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6 mM) [31]. The rates of Cl
2 transport obtained for the EE and
E314A mutants were too low to allow a reliable determination of
kinetic parameters.
At steady state in Figure 2A–C, the outwardly directed chemical
Cl
2 gradient is in equilibrium with the inwardly directed Dy and
DpH (Zlog[Cl
2]in/[Cl
2]out=2(nDy2mZDpH) in which
Z=59 mV). From the data, n was calculated as 0.760.1
(Figure 3A), and m=0.860.1 (Figure 3B) and 0.860.2
(Figure 3C). These estimates indicate an apparent net stoichiom-
etry of 2(+)/Cl
2 anion and 1 H
+/Cl
2, respectively, pointing to
electrogenic symport of 1X
+:1Cl
2:1H
+.
Figure 3. Ion-coupled transport in proteoliposomes. A, B,
36Cl
2 uptake (100 mM) by LmrA-MD (N), E314A LmrA-MD (e), EE LmrA-MD (&)o r
empty liposomes (n) in the presence of a Dy (interior negative) of 2120 mV (A) or -ZDpH (interior alkaline) of 249 mV (B). In the duplicate
experiment for LmrA-MD (%) in (B), the addition of uncoupler (valinomycin plus nigericin, 1 mM each) at the arrow resulted in efflux of accumulated
36Cl
2, indicating concentrative uptake of the ion. C, DpH (interior alkaline)-dependent
36Cl
2 uptake by LmrA (N), EE LmrA (&) or empty liposomes
(n). D, DpH (interior alkaline)-dependent uptake of non-radioactive Cl
2 (1 mM) by LmrA is observed as a quench in the fluorescence of the SPQ
fluorophore trapped in the lumen of the proteoliposomes. Quenching was also observed in empty liposomes (control) in the presence of the Cl
2/
OH
2 antiporter TBT-Cl (1 mM). E, Kinetic analysis of DpH (interior alkaline)-dependent
36Cl
2 uptake by LmrA. F, DpH (interior alkaline)-dependent
uptake of
22Na (25 mM) by LmrA-MD. G, Uptake of unlabelled Na
+ (10 mM) by LmrA was detected as an increase in the fluorescence of the
membrane-impermeable sodium green probe trapped in the lumen. H, Na
+ (100 mM) stimulates the DpH-dependent uptake of
36Cl
2 (100 mM) by
LmrA compared to control containing 99 mM NMG
+ plus 1 mMN a
+. I, H
+ efflux in proteoliposomes loaded with pH probe BCECF in the presence of an
outwardly directed NaCl gradient. Control, empty liposomes. (n=5)
doi:10.1371/journal.pone.0006137.g003
H
+-Na
+-Cl
2 Symport by LmrA
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Consistent with the electrophysiology experiments showing Na
+/
K
+ conductance by LmrA-MD, Na
+ can participate in the X
+-Cl
2-
H
+ co-transport reaction. Upon the imposition of a DpH (pH 7.6in/
pH 6.8out),
22Na
+ uptake in proteoliposomes containing LmrA-MD
was observed above the equilibration level in empty liposomes
consistent with sodium-proton co-transport (Figure 3F). The DpH-
dependent accumulation of Na
+ could also be monitored in LmrA-
containingproteoliposomes loadedwitha Na
+-sensitive fluorophore
(Figure 3G). In both types of experiments, LmrA(-MD)-mediated
Na
+ transport was strongly reduced in the absence of the DpH and
identical to levels in empty liposomes. In agreement with H
+-Na
+-
Cl
2 co-transport, the presence of Na
+ stimulated the DpH-
dependent uptake of
36Cl
2 in LmrA-containing proteoliposomes
compared to a control in which the Na
+ concentration was reduced
100-fold by replacement with NMG
+ (Figure 3H). In analogous
experiments with the radioactive K
+ analog
86Rb
+,n oDpH-
dependent accumulation was observed in LmrA-MD containing
proteoliposomes above control (data not shown), which most likely
reflects the low affinity of LmrA-MD for K
+ relative to Na
+.
As the DpH can drive Na
+ and Cl
2 transport by LmrA,
downhill transport of these ions by LmrA might be able to
regenerate this DpH. To test this hypothesis, (proteo)liposomes
were prepared containing a pH-sensitive fluorophore. When the
(proteo)liposomes were diluted to create an outwardly directed
NaCl concentration gradient (5 mMin/0.05 mMout) the simulta-
neous efflux of Na
+,C l
2 and protons by LmrA was observed as an
increase in luminal pH of (15.161.1)610
23 units/min (Figure 3I).
The enhanced proton efflux was not observed for empty control
liposomes or proteoliposomes containing E314A LmrA (pH
increase of (5.261.0)610
23 versus (6.261.3)610
23 units/min,
respectively). No differences in the luminal pH were observed
upon dilution without the imposition of the NaCl gradient (data
not shown).
Ion transport in intact cells
The addition of glucose as a source of metabolic energy to cells
pre-equilibrated with 100 mMN a
36Cl elicited
36Cl
2 efflux by
LmrA but not by an ATPase-deficient LmrA mutant in which the
catalytic K388 residue in the Walker A region of the NBD was
deleted (DK388) [31] (Figure 4A). Efflux was also not observed for
non-expressing control cells or cells expressing EE LmrA. The
notion that LmrA can transport salt in an ATP-dependent fashion
is supported by the inorganic ion-dependent stimulation of the
Figure 4. Ion transport in intact cells. A, Cl
2 efflux in cells preloaded with Na
36Cl (100 mM) upon the addition of glucose (&, LmrA; %, non-
expressing control; X, EE LmrA; #, DK388 LmrA). B, Effect of the concentration of Na
+, NMG
+ or Cl
2 on the ATPase activity of purified LmrA (open
symbols) or LmrCD (N) measured at 2 mM Mg-ATP. C,D,E, H
+ efflux in energized cells, loaded with pH probe CFDASE to monitor the intracellular pH
(pHin) in the absence (C) or presence of (D) 0.25 M NaCl or (E) 0.672 M sucrose in the external buffer (each equivalent to 521 mOsm) (&, LmrA; %,
non-expressing control; X, EE LmrA;N, E314A LmrA; m, DK388 LmrA). Metabolic energy was generated in the cells by the addition of 20 mM glucose
(at t=0 min in the figures), 15 min after the addition of the NaCl or sucrose or solvent control. (n=8)
doi:10.1371/journal.pone.0006137.g004
H
+-Na
+-Cl
2 Symport by LmrA
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(Figure 4B). A maximal stimulation was observed for NaCl,
whereas an intermediate level of stimulation was obtained for
(Na)Hepes and (NMG)Cl. On the other hand, (NMG)Hepes did
not affect the basal ATPase activity suggesting that the ion-
dependent stimulation of the LmrA-ATPase activity is due to a
specific interaction with Na
+ and Cl
2. This notion is also
supported by the observation that, in contrast to LmrA, the
ATPase activity of the purified multidrug ABC transporter
LmrCD from L. lactis [33] is not stimulated by NaCl up to a
concentration of 0.3 M (Figure 4B).
H
+-Na
+-Cl
2 co-transport by LmrA was also indicated in H
+
efflux measurement from cells. Estimation of the intracellular pH in
thecellswithafluorescentpHindicatorrevealedanalkalinizationof
the cytosol in LmrA expressing cells, consistent with H
+ efflux by
LmrA (Figure 4C). The external pH was constant during the time
course of these experiments (not shown). Interestingly, the addition
of 0.25 M NaCl to the extracellular buffer did not have an
immediate effect on alkalinization, but strongly stimulated proton
efflux after a prolonged exposure of the cells for 15 min (Figure 4D).
This time dependence suggests that the H
+-Na
+-Cl
2 co-transport
reaction is enhanced by elevated concentrations of NaCl in the
cytosol. NaCl could, to a limited extend, be replaced by KCl at a
similar osmolality (521 mOsm) (not shown) but could not be
replaced by sucrose (Figure 4E), indicating an ionic requirement in
the stimulation. The E314A, EE and DK388 mutations in LmrA
strongly reduced the elevation of the cytosolic pH in the presence of
NaCl (Figure 4D), consistent with their inhibition of LmrA-
mediated ion transport (Figure 3–4A).
LmrA activity enhances cell survival
A relationship was found between LmrA activity and cell
viability during ionic downshift. When cells were pre-exposed to
100 mM NaCl plus 0.5 M sucrose for 30 min, and subsequently
diluted 100-fold in ultra pure H2O, the cells expressing LmrA
survived the downshock with a significant gain of viability
compared to the non-expressing control (Figure 5A). Cell survival
required exposure to NaCl, which could partially be substituted by
KCl and Na2SO4, but not by sucrose only (Figure 5A). These data
are consistent with the stimulatory effect of these salts, but not of
sucrose, on LmrA-mediated H
+ efflux (Figure 4D). In contrast, no
differences in cell survival between LmrA expressing cells and
control cells were observed following a minor 4-fold downshock
(Figure 5A). The survival of NaCl adapted cells was strongly
reduced for the EE and DK388 mutants (Figure 5B), which are
impaired in ion transport (Figure 2–4), indicating that LmrA itself
can diminish irreversible damage in salt-exposed cells during the
ionic downshock.
Discussion
Collectively, the observations on proton-coupled Cl
2 transport,
proton-coupled Na
+ transport, Na
+-dependent Cl
2 transport, and
NaCl-coupled proton transport by purified protein in proteolipo-
somes (Figure 3) provide compelling evidence that both LmrA-
MD and LmrA can mediate an electrogenic H
+-Na
+-Cl
2 symport
reaction. An alternative explanation in which LmrA-MD/LmrA
might regulate the activity of an unidentified, associated
membrane protein appears less likely since an associated protein
was not observed in our purified protein preparations in analyses
based on silver–stained SDS-PAAGE, N-terminal amino acid
sequencing (data not shown) and non-dissociating mass spectrom-
etry (Figure 1). Consistent with previous cross-linking experiments
on LmrA and LmrA-MD [11,29], and studies demonstrating that
(i) an inactive LmrA mutant exhibits negative dominance over an
active wild-type LmrA protein in a co-reconstituted liposomal
system, and (ii) the covalent fusion of two wild-type LmrA
monomers yields a functional transporter whereas the fusion of a
wild-type monomer and the inactive mutant monomer does not
[11], the mass spectra (Figure 1) showed predominant peaks for
the LmrA and LmrA-MD dimers, and showed no evidence for
other proteinacious binding partners. Ion transport was strongly
inhibited by the distinct EE and E314A mutations in the MD, and
Walker A DK388 mutation in the NBD (Figure 2–4) the latter of
which significantly reduces the LmrA ATPase activity down to 4%
of wildtype level [31,34]. Taken together, the data suggest that
LmrA/LmrA-MD itself is responsible for inorganic ion transport.
Current advancements in the biochemistry and structural
biology of ABC transporters indicate that these systems operate
by a mechanism in which binding sites in the MDs for transport
substrate(s) are alternately exposed to the inside and outside
surface of the membrane in response to the ATP-driven
dimerization of NBDs and their dissociation following ATP
Figure 5. LmrA activity enhances cell survival. A, Viability of
energized cells (solid bar, LmrA; grey bar, non-expressing control)
adapted for 30 min in buffer containing 0.5 M sucrose without or with
100 mM NaCl, 100 mM KCl or 50 mM Na2SO4, followed by 100-fold
dilution into ultrapure water, or in buffer containing 0.125 M sucrose
and 25 mM NaCl (control referred to as 4-fold dilution). B, Effect of
mutations in LmrA on the viability after dilution of cells pre-exposed to
100 mM NaCl plus 0.5 M sucrose under conditions as in (A). (n=10)
doi:10.1371/journal.pone.0006137.g005
H
+-Na
+-Cl
2 Symport by LmrA
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the DK388 mutation of LmrA-mediated Cl
2 and H
+ efflux from
ATP-containing cells (Fig. 4A–D) is consistent with this notion,
and suggests that substrate (H
+,N a
+ and Cl
2) efflux is dependent
on phosphate-bond energy derived from ATP hydrolysis.
Evidence for ATP-dependence of transport by LmrA was also
previously obtained in drug transport studies [10,11,31,37].
However, electrochemical ion gradient-dependent H
+-Na
+-Cl
2
symport by LmrA in proteoliposomes in the absence of ATP
implies that this reaction can occur in the absence of a catalytic
cycle at the NBDs; indeed, the same reaction can be detected for
LmrA-MD that does not contain the NBD. Hence, in the absence
of the successful dimerization of NBDs and/or their conforma-
tional coupling in the LmrA transporter, the MDs operate in a
reversible, secondary-active mode in which the direction of
transport is dictated by the orientation and magnitude of the
electrochemical substrate (H
+,N a
+ and Cl
2) gradients. It is
interesting to note that for the LmrA homologue Sav1866, which
exhibits a similar reversibility of transport as LmrA [21], the
homodimer was co-crystallized with a Na
+ ion bound in the hinge
region connecting the a-helical and b-sheet subdomains in each
NBD [20], where these ions might affect the dimerisation of NBDs
and/or their conformational coupling to MDs. Ion sensing in
LmrA might also occur by the cytosolic N-terminal elbow helix
which is predicted to be in close proximity to the inside surface of
the membrane [20]. In LmrA, this helix contains 8 basic residues
(R10, K14, K18, K22, K26, R29, K32, R34) which could bind
anions (Cl
2) and which, in competition with cations (Na
+), could
interact with acidic lipids and/or neighbouring residues in
transmembrane helix 2, 3 and 6. Consequently, the interactions
at the elbow helix might occur in an ionic strength (NaCl)-
dependent manner. The phenotype of the EE mutant (Figure 2–5)
suggests that the simultaneous replacement of K32 and R34 by E
in the elbow helix interferes with its function. Hence, ion-
dependent regulatory mechanisms might exist in this type of
multidrug ABC exporter that affect transport activity.
LmrA shares its ability to conduct Cl
2 (Figure 2) with the only
established ABC Cl
2 channel CFTR [38], in which ATP binding
triggers channel opening and ATP hydrolysis triggers channel
closing through the effect of nucleotide binding/hydrolysis on
NBD dimerisation [39]. In addition, LmrA might share its ability
to conduct Cl
2 with human ABCB1, the expression of which was
reported to be associated with a Cl
2 dependent regulation of
intracellular pH in chinese hamster ovary fibroblasts [40,41] and
with volume-dependent Cl
2 currents in mouse fibroblasts [42].
Whereas ABCB1 was suggested to act as a Cl
2 channel [42], our
data on LmrA-mediated, proton-motive force (interior negative
and alkaline)-dependent accumulation of Cl
2 in proteoliposomes
(Figure 3A–D) and the release of pre-accumulated Cl
2 from
proteoliposomes upon dissipation of the proton-motive force by
protonophore (Figure 3B) indicate that LmrA operates as a
proton-coupled Cl
2 transporter. Recently, members of the
Chloride Channel (ClC) family were shown to mediate a rapid
2Cl
2/H
+ antiport reaction, indicating a close connection between
transporters and channels in this protein family [43–46]. As LmrA
and CFTR are structurally related proteins, our findings on
LmrA-mediated Cl
2 transport might point to a mechanistic
relationship between transporters and channels in the ABC
superfamily.
The observations on salt transport by LmrA and the increased
survival of salt-adapted LmrA-expressing cells during ionic
downshift (Figure 5) imply a novel link between LmrA activity
and the homeostatic control of the intracellular pH and NaCl
concentration, and represent an interesting example of the notion
that multidrug ABC transporters can have physiological roles that
go beyond the transport of toxic compounds. We found that LmrA
expression does not confer resistance on lactococcal cells to NaCl
or acidity during exponential growth (data not shown) where ion
homeostasis is in place. Therefore, the beneficial action of LmrA
on cell survival appears to be relevant during periods of disturbed
ionic balance. It should be mentioned that the deletion mutant
lacking the lmrA gene did not reveal a significant growth or survival
phenotype compared to the wildtype background in L. lactis
NZ9000 (data not shown) suggesting insufficient expression of
genomic lmrA under laboratory conditions in M17 medium, or a
redundancy in LmrA function as was observed for mechanosensi-
tive channel proteins in E. coli [47,48]. The MS data (Figure 1)
indicate binding of a specific lipid, cardiolipin, by the LmrA dimer.
As it was previously proposed that LmrA might act as a flippase for
hydrophobic compounds including lipid [11,12,49], the potential
role of lipid transport by LmrA in cell membrane homeostasis
during salt stress (including the regulation of lipid composition,
membrane tension and/or surface area) remains to be determined.
Materials and Methods
Cell and membrane preparations
The expression of LmrA, LmrA-MD, LmrA(-MD) mutants, and
LmrCD in the drug-hypersensitive L. lactis strain NZ9000 DlmrA
DlmrCD [31,33], the solubilization and affinity-purification of these
proteins in n-dodecyl b-D-maltoside (DDM, Anatrace)-containing
solutions, and the reconstitution of purified proteins at a protein-
lipid ratio of 1:100 (w/w) in Triton X-100 (BDH Chemicals)-
destabilized proteoliposomes (with an internal volume of 10.4 ml/
mg lipid) in 50 mM KPi (pH 7.6), 2 mM MgSO4 was performed
by methods as described previously [21,29,32,49]. For mass
spectrometry of LmrA, protein was purified as above using
dodecyl octa(ethylene oxide) (C12E8, Anatrace) rather than DDM
at equivalent w/v concentration. To determine the ATPase
activity of LmrA, protein was solubilized in C12E8 and bound to
Ni
2+-nitrilotriacetic acid (Ni-NTA) resin as above, and subse-
quently washed and eluted with buffer containing 0.1% (w/v) fos-
choline-12 (Anatrace).
Genetic manipulations
Site directed mutagenesis was performed on pGHLmrA [30]
using the QuikChange kit (Stratagene). The K32E/R34E (EE)
double mutant was generated with primers 59- GCA GAA CCA
GAG TAT CTC TTT TTT GTG ATT G -39 and 59-TAC TCT
GGT TCT GCT GCA CGA ATT AAT TTG-39. To generate
EE LmrA-MD, the coding region for the MD [29] was PCR
amplified using the mutant lmrA gene as a template.
Mass spectrometry
Analyses were performed using a nanoflow ES mass spectrom-
eter Q-ToF2 (Micromass), which has been modified for transmis-
sion and detection of ions at high m/z ratios [50]. Aliquots of
complex-containing solutions (2 mLa t,10 mM concentration in
190 mM C12E8) were introduced via gold-coated nanoflow
electrospray capillaries, prepared in-house. The following exper-
imental parameters were used to record mass spectra of 1 mg/ml
LmrA and LmrA-MD: needle voltage of 1.8 kV and MCP
2350 V, 150 V cone and 100 V collision voltages for LmrA-MD
and 200 V both cone and collision voltages for LmrA.
Electrophysiological measurements
Ion conductance was measured by the ‘dip-tip’ technique [51].
The external bath and the tip of a micropipette were filled with
H
+-Na
+-Cl
2 Symport by LmrA
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KCl and 10 mM NaCl. A planar lipid bilayer in the tip of the
pipette was formed using 1-palmitoyl-2-oleyl-sn-glycero-3-phos-
phocholine and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(Avanti Polar lipids) in a ratio of 7:3 (w/w), which increased the
resistance of the pipette from about 7 MV to about 75 GV.
Proteoliposomes prepared from synthetic lipids fused with the
planar lipid bilayer following their addition to the external bath at
a concentration of 19 mg protein/ml.
Biochemical assays
The transport of radioactive chloride or sodium ions was
measured by rapid filtration after 100-fold dilution in 50 mM KPi
(pH 6.8), 2 mM MgSO4, or buffers and conditions as described
[52], containing 100 mMN a
36Cl (16 mCi/g) (MP Biomedicals) or
25 mM
22NaCl (100 mCi/mg) (Amersham Biosciences). The
transport of H
+ in proteoliposomes in 5 mM KPi (pH 7.6) or
non-radioactive Cl
2 (1 mM) or Na
+ (10 mM) was measured by
fluorimetry using 50 mM2 9,79-bis-(2-carboxyethyl)-5-(and-6)-car-
boxyfluorescein (BCECF) [29], 300 mM 6-methoxy-N-(3-sulfopro-
pyl) quinolinium (SPQ), or 1 mM membrane-impermeable
sodium green (Molecular Probes), respectively, that was trapped
in the lumen. Cells in phosphate-buffered saline were loaded with
30 mM 5(6)-carboxyfluorescein diacetate succinimidyl ester
(CFDASE) (Molecular Probes) for detection of H
+ transport
[53], and washed and resuspended in 50 mM KPi (pH 6.0).
Fluorescence was calibrated in the presence of nigericin
(pHin=pH out) using a micro pH electrode for measurement of
pHout. ATPase activities on purified protein (1 mgi n3 0ml buffer)
were estimated by the malachite green method as described [31]
using LmrCD in 0.05% (w/v) DDM or LmrA in 0.1% (w/v) fos-
choline-12.
Cell viability
Cell suspensions (OD660=0.5) were pre-incubated for 30 min
in 50 mM (NMG)Hepes (pH 7.4) plus 20 mM glucose with
additions as indicated in the legend to Figure 5A–B after which
they were 100-fold diluted into ultra pure water. After 10 min,
cells were diluted 10
6-fold and 0.1 ml was plated onto M17 agar
plates supplemented with 5 mg/ml chloramphenicol and 0.5% (w/
v) glucose. The plates were incubated overnight at 30uC and the
number of colony forming units (cfu)/plate was counted. The
100% value refers to cfu/plate immediately prior to the dilution of
the cells in water, and was equal to 48 and 45 for LmrA-expressing
and control cells, respectively.
Data analysis
All statistical analyses were performed using the paired
Student’s t-test with a 95% confidence interval for the sample
mean, based on n independent observations with different cell
batches or (proteo)liposome preparations.
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